Literature DB >> 17954504

Risk of antigen excess in serum free light chain measurements.

Sandrine Daval, Arlette Tridon, Nicole Mazeron, Jean-Michel Ristori, Bertrand Evrard.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17954504     DOI： 10.1373/clinchem.2007.093377

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  10 in total

1.  Screening panels for monoclonal gammopathies: time to change.

Authors:  Jerry A Katzmann
Journal:  Clin Biochem Rev       Date:  2009-08

2.  Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma.

Authors:  S H K Murng; L Follows; P Whitfield; J A Snowden; K Swallow; K Green; R Sargur; W Egner
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

3.  Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.

Authors:  V González-Calle; J Dávila; F Escalante; A G de Coca; C Aguilera; R López; A Bárez; J M Alonso; R Hernández; J M Hernández; P de la Fuente; N Puig; E M Ocio; N C Gutiérrez; R García-Sanz; M V Mateos
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

Review 4.  Kidney disease associated with plasma cell dyscrasias.

Authors:  Eliot C Heher; Nelson B Goes; Thomas R Spitzer; Noopur S Raje; Benjamin D Humphreys; Kenneth C Anderson; Paul G Richardson
Journal:  Blood       Date:  2010-05-12       Impact factor: 22.113

5.  Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies.

Authors:  Sandra Davern; Lian X Tang; Teresa K Williams; Sallie D Macy; Jonathan S Wall; Deborah T Weiss; Alan Solomon
Journal:  Am J Clin Pathol       Date:  2008-11       Impact factor: 2.493

Review 6.  Kidney disease and multiple myeloma.

Authors:  Eliot C Heher; Helmut G Rennke; Jacob P Laubach; Paul G Richardson
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-18       Impact factor: 8.237

7.  The analytical performance evaluation of Freelite™ Human Kappa Free and Human Lambda Free on the SPAPLUS™ immunoturbidimetric analyzer.

Authors:  Kyong-Ho Cha; Yang Bo Sim; Hyojin Chae; Hae-il Park; Myungshin Kim; Yonggoo Kim
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

8.  T cell receptor rearrangements in a patient with γ-heavy chain disease: A case report.

Authors:  Hebing Zhou; Wenming Chen; Juan Zhang; Hui Zeng; Yuan Jian; Chenxiao Fu
Journal:  Oncol Lett       Date:  2016-05-04       Impact factor: 2.967

9.  The spot urine protein/creatinine ratio is a simple, rapid and inexpensive method for monitoring patients with light-chain multiple myeloma.

Authors:  Dennis Cooper
Journal:  NDT Plus       Date:  2010-04-26

10.  The value of serum immunoglobulin free light chain assessment in patients with monoclonal gammopathies and acute renal failure.

Authors:  Mustafa Cirit; Atilla Uzüm; Pınar Ozen; Banu A Sentürk; Giray Bozkaya; Bahriye Payzin; Orçun Ural
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.